Smith & Nephew SNATS (NYSE:SNN) Shares Gap Up – Here’s What Happened

Posted by Francis Steltz on Sep 1st, 2026

Smith & Nephew SNATS, Inc. (NYSE:SNN – Get Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $28.76, but opened at $29.63. Smith & Nephew SNATS shares last traded at $29.3050, with a volume of 298,126 shares changing hands.

Analyst Ratings Changes

SNN has been the topic of a number of research reports. Zacks Research downgraded shares of Smith & Nephew SNATS from a “hold” rating to a “strong sell” rating in a research note on Friday, August 7th. Barclays cut Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a research report on Wednesday, August 5th. Wall Street Zen upgraded Smith & Nephew SNATS from a “hold” rating to a “buy” rating in a research note on Monday, August 24th. Weiss Ratings lowered Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, June 11th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of Smith & Nephew SNATS in a research note on Thursday, August 6th. Two analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $30.93.

Read Our Latest Analysis on Smith & Nephew SNATS

Smith & Nephew SNATS Stock Up 1.2%

The company has a debt-to-equity ratio of 0.62, a current ratio of 2.14 and a quick ratio of 1.11. The company’s 50-day simple moving average is $30.21 and its 200 day simple moving average is $31.61.

Smith & Nephew SNATS Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Friday, November 6th. Investors of record on Friday, October 2nd will be paid a $0.312 dividend. This represents a dividend yield of 205.0%. The ex-dividend date of this dividend is Friday, October 2nd.

Institutional Investors Weigh In On Smith & Nephew SNATS

A number of large investors have recently bought and sold shares of SNN. Corient Private Wealth LP increased its position in Smith & Nephew SNATS by 3.7% during the second quarter. Corient Private Wealth LP now owns 26,018 shares of the medical equipment provider’s stock worth $750,000 after buying an additional 932 shares during the last quarter. Plan A Wealth LLC lifted its position in shares of Smith & Nephew SNATS by 16.5% in the second quarter. Plan A Wealth LLC now owns 8,607 shares of the medical equipment provider’s stock worth $248,000 after buying an additional 1,221 shares during the last quarter. Concurrent Investment Advisors LLC acquired a new stake in shares of Smith & Nephew SNATS in the second quarter worth about $313,000. Rakuten Investment Management Inc. bought a new stake in shares of Smith & Nephew SNATS during the 2nd quarter worth about $732,000. Finally, Empowered Funds LLC bought a new stake in shares of Smith & Nephew SNATS during the 2nd quarter worth about $824,000. 25.64% of the stock is currently owned by institutional investors.

About Smith & Nephew SNATS

(Get Free Report)

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.